Colfax Corporation (CFX): Price and Financial Metrics
CFX Price/Volume Stats
| Current price | $117.18 | 52-week high | $121.89 |
| Prev. close | $40.59 | 52-week low | $35.66 |
| Day low | $116.64 | Volume | 984,433 |
| Day high | $121.89 | Avg. volume | 1,387,519 |
| 50-day MA | $40.36 | Dividend yield | N/A |
| 200-day MA | $45.55 | Market Cap | 18.90B |
CFX Stock Price Chart Interactive Chart >
Colfax Corporation (CFX) Company Bio
Colfax Corporation is a manufacturing and engineering company that provides gas- and fluid-handling and fabrication technology products and services to commercial and governmental customers around the world under the Howden, Colfax Fluid Handling and ESAB brands. The company was founded in 1860 and is based in Annapolis Junction, Maryland.
Latest CFX News From Around the Web
Below are the latest news stories about Colfax CORP that investors may wish to consider to help them evaluate CFX as an investment opportunity.
Colfax (CFX) Q4 Earnings & Revenues Surpass Estimates, Up Y/YColfax's (CFX) fourth-quarter 2021 net sales increase 23.6% year over year on impressive performance across its segments. |
Colfax Non-GAAP EPS of $0.59 beats by $0.01, revenue of $1.02B beats by $10MColfax press release (NYSE:CFX): Q4 Non-GAAP EPS of $0.59 beats by $0.01. Revenue of $1.02B (+23.2% Y/Y) beats by $10M. Shares -3.22% PM. 2022 Financial Outlook: Colfax reported that it expects strong sales and profit growth in 2022 for both of its businesses with typical seasonal patterns and improving business... |
Colfax (CFX) Beats Q4 Earnings and Revenue EstimatesColfax (CFX) delivered earnings and revenue surprises of 3.51% and 2.15%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock? |
DJO® Showcases Growing Foot & Ankle Portfolio at ACFAS Scientific ConferenceDALLAS, February 22, 2022--DJO®, a leading global provider of medical technologies, announced it will showcase their growing Foot & Ankle offerings at ACFAS 2022. |
Colfax Corporation Announces Fourth Quarter and Full Year 2021 ResultsStrong operating performance supported $0.06 EPS from continuing operations and $0.59 of adjusted EPSAchieved a strong quarter of cash flow, contributing to full year operating cash flow of $356 million and free cash flow of $277 millionPositioned for separation into two independent public companies near the end of the first quarter 2022 with strong growth outlooks for both businesses Wilmington, DE, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technolo |
CFX Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | -11.51% |
| 5-year | 28.61% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | 0.00% |
| 2021 | 20.21% |
| 2020 | 5.11% |
| 2019 | 74.07% |
Continue Researching CFX
Here are a few links from around the web to help you further your research on Colfax CORP's stock as an investment opportunity:Colfax CORP (CFX) Stock Price | Nasdaq
Colfax CORP (CFX) Stock Quote, History and News - Yahoo Finance
Colfax CORP (CFX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...